Form 4: Eli Lilly Executive Boosts Stake with Share Acquisition

Eli Lilly's EVP & President of International, Patrik Jonsson, acquired over 4,800 shares of common stock at a price of $1,044.67 per share.

Summary

• Patrik Jonsson, EVP & President, LLY Int'l, acquired 4,818.052 shares of Eli Lilly & Co. common stock.
• The acquisition occurred on February 9, 2026, at a price of $1,044.67 per share.
• Following this transaction, Jonsson directly owns 60,646.62 shares and indirectly owns 611.2 shares through a 401(k) plan.
• The transaction was executed under a Rule 10b5-1(c) plan, which allows insiders to set up a predetermined plan to buy or sell company stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as an executive's personal investment in company stock often reflects confidence in future performance, though it's a single transaction.

Positives

• An executive acquiring a significant number of shares can signal strong confidence in the company's future performance and valuation.
• The acquisition was made at a substantial price of $1,044.67 per share, representing a considerable personal investment by the insider.

Risks

• While an insider acquisition can signal confidence, it does not guarantee future stock performance or insulate against market downturns.

Future Outlook

N/A. This filing reports a historical insider transaction and does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider purchases, especially by high-ranking executives like an EVP & President of International, can be interpreted by the market as a positive signal regarding the company's internal outlook. This transaction for Eli Lilly, a major pharmaceutical company, occurs in an industry often characterized by significant R&D investments and long product development cycles, where insider confidence can be particularly impactful.

Stakeholder Impact

• Shareholders: May view the executive's purchase as a sign of confidence in the company's future, potentially influencing positive sentiment.
• Employees: Could interpret the executive's investment as a positive indicator of the company's stability and future prospects.

Key Dates

Recommendation

The acquisition of shares by a key executive, particularly under a 10b5-1 plan, suggests management confidence in Eli Lilly's long-term prospects. However, this single transaction, while positive, does not provide sufficient fundamental or strategic information to warrant a 'buy' recommendation on its own. It primarily reinforces a 'hold' position for investors already considering the stock, indicating internal alignment with the company's trajectory.

Keywords

Eli Lilly, LLY, Insider Trading, Form 4, Stock Acquisition, Patrik Jonsson, Executive Stock Purchase, 10b5-1 Plan